Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-02-19 @ 5:33 PM
Study NCT ID:
NCT02392793
Status:
COMPLETED
Last Update Posted:
2021-02-09
First Post:
2015-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
Sponsor:
St. Jude Children's Research Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-06
First Submit QC Date:
None
Study First Post Date:
2015-03-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-08
Last Update Post Date:
2021-02-09
Last Update Post Date Type:
ACTUAL